The market research report on the global organoid technology market predicts the market to grow at a CAGR of 28.11% during the 2018-2024 period. Organoids are three-dimensional (3D) cell cultures that incorporate some of the key features of the represented organ. These in vitro culture systems contain
a self-renewing stem cell population which differentiates into multiple, organ-specific cell types that exhibit spatial organization similar to the corresponding organ and are capable of recapitulating some functions of that organ providing a highly physiologically relevant system.

Organoid technology refers to the growing of organs or a miniaturized version of the organs which shows realistic microanatomy. Increasing expenditure on healthcare research coupled with the growing biotech
the industry is expected to drive the organoid market growth during the forecast period.